臨床試驗

CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation

NCT：NCT06959121 · RECRUITING

NCT IDNCT06959121

狀態RECRUITING

開始日期2025-10-23

SponsorPulse Biosciences, Inc. (INDUSTRY)

First posted2025-05-06

Last updated2026-09-09

簡要摘要

The primary objective of this Pivotal study is to demonstrate the safety and effectiveness of the Pulse Biosciences nsPFA™ Cardiac Surgery System in treating atrial fibrillation during concomitant cardiac surgical procedures.

官方來源

在 ClinicalTrials.gov 上查看 →

資料來自 ClinicalTrials.gov API。最新狀態請參閱官方紀錄。